Politics
|
FOR IMMEDIATE RELEASE |
CONTACT: US PIRG Larry
McNeely |
Health Care Reform and the Biologics Bill: US PIRG Supports Innovation, Not Monopoly
WASHINGTON - July 14 - A top, respected consumer group threw its weight behind proposals to speed generic versions of protein-based wonder drugs to market on Tuesday.
In testimony before Congress, U.S. Public Interest Research Group's Health Care Advocate Larry McNeely lauded the effort.